Immunosuppressive Strategies for Long-term Success in Heart Transplantation CME/CE

Author Information and Disclosures

Release Date: February 28, 2008; Valid for credit through February 28, 2009

Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians;
Nurses - 1.0 nursing contact hours (None of these credits is in the area of pharmacology);
Pharmacists - 1.0 ACPE continuing education credits for pharmacists (0.1 CEUs)
Case Managers - 2 hours (Commission for Case Manager Certification)

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Medscape.
Astellas
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Identify the indications for heart transplantation
  2. Explain the importance of individualizing the immunosuppression regimen for heart transplant recipients
  3. Discuss the importance of the endomyocardial biopsy in monitoring for and diagnosing acute cellular rejection in the cardiac allograft
  4. Compare and contrast the adverse effects of maintenance immunosuppressive agents most commonly used to prevent and treat rejection in heart transplant recipients
  5. Describe the pathophysiologic process of cardiac allograft vasculopathy and pharmacologic interventions for prevention and treatment
Authors and Disclosures

Jon A. Kobashigawa, MD
Disclosure: Jon A. Kobashigawa, MD, has disclosed that he has received contract research support and consultation fees from Astellas, Novartis, Roche, and XDx Pharma.


Susan L. Smith, MN, PhD
Disclosure: Susan L. Smith, MN, PhD, has disclosed no relevant financial relationships.


Sarah L. Kennedy, PhD
Disclosure: Sarah L. Kennedy, PhD, has disclosed no relevant financial relationships.
 
University of Kentucky
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the University of Kentucky College of Medicine. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Kentucky College of Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their fields.

The University of Kentucky is an Equal Opportunity University.

Contact This Provider

 
Educational Review Systems
Educational Review Systems is an approved provider of continuing education in nursing by ASNA, an accredited provider by the ANCC/Commission on Accreditation and will offer a maximum of 1.0 hour. Provider #5-115-07-050 Educational Review Systems is also approved for nursing continuing education by the state of California and the District of Columbia
 
ACPE logoTG Medical Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The activity entitled, Immunosuppressive Strategies for Long-term Success in Heart Transplantation, is approved for 1 hour credit (0.1 CEU). TG Medical Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
The program number is 454-999-07-044-H01-P and initial release date is 02/28/2008.

This program has been approved by the Commission for Case Manager Certification for 2 hours.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.